Search research articles
Contact Us
Filters
Showing results (51-60 of 110) with videos related to
Page
of 11
Sort By:
La Tunisie Medicale
|
June 8, 2006
[Biological investigation of thyroid cancer]
Hayet Douik, Abderraouf Ghanem, Aouatef Jmal, et al.
La Tunisie Medicale
|
September 24, 2004
[Breast myoepithelioma. Report of a new case and review of literature]
Moez Kdous, Rim Hachicha, Amor Gamoudi, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
April 15, 2026
Immunotherapy "stop and go" and early discontinuation: A viable option in limited resources setting
Nesrine Mejri, Myriam Saadi, Saif Baklouti, et al.
Bulletin Du Cancer
|
February 1, 2020
Use of complementary and alternative medicine in cancer: A Tunisian single-center experience
Soumaya Labidi, Sana Ennouri, Haifa Rachdi, et al.
Journal of Adolescent and Young Adult Oncology
|
April 5, 2024
Navigating the Cancer Journey: Experiences and Perspectives of Young Adult Patients in Tunisia
Yosra Berrazaga, Haifa Rachdi, Myriam Saadi, et al.
Bulletin Du Cancer
|
July 10, 2004
[Contribution of serum Cyfra 21-1 in nasopharyngeal carcinoma in Tunisia]
Aouatef Jmal, Hamouda Boussen, Monia Abdennebi, et al.
Breast Disease
|
March 6, 2018
Forkhead box M1 (FOXM1) expression predicts disease free survival and may mediate resistance to chemotherapy and hormonotherapy in male breast cancer
Syrine Abdeljaoued, Lhem Bettaieb, Meher Nasri, et al.
La Tunisie Medicale
|
February 8, 2008
[Seric soluble interleukin-2 receptor alpha in nasopharyngeal carcinoma in Tunisia. Prospective study about 45 cases]
Aouatef Jmal, Abderraouf Ghanem, Hamouda Boussen, et al.
Journal of Oral Science
|
June 23, 2017
HLA-A*26-A*30 and HLA-DRB1*10 could be predictors of nasopharyngeal carcinoma risk in high-risk Tunisian families
Nehla Mokni-Baizig, Yosr Gorgi, Mohamed Elghourabi, et al.
Presse Medicale (Paris, France : 1983)
|
December 24, 2014
[Medical therapies for locally advanced/metastatic kidney cancer]
Mehdi Afrit, Yosra Yahyaoui, Aderrazek Bouzouita, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 110) with videos related to
Sort By:
Page
of 11
La Tunisie Medicale
|
June 8, 2006
[Biological investigation of thyroid cancer]
Hayet Douik, Abderraouf Ghanem, Aouatef Jmal, et al.
La Tunisie Medicale
|
September 24, 2004
[Breast myoepithelioma. Report of a new case and review of literature]
Moez Kdous, Rim Hachicha, Amor Gamoudi, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
April 15, 2026
Immunotherapy "stop and go" and early discontinuation: A viable option in limited resources setting
Nesrine Mejri, Myriam Saadi, Saif Baklouti, et al.
Bulletin Du Cancer
|
February 1, 2020
Use of complementary and alternative medicine in cancer: A Tunisian single-center experience
Soumaya Labidi, Sana Ennouri, Haifa Rachdi, et al.
Journal of Adolescent and Young Adult Oncology
|
April 5, 2024
Navigating the Cancer Journey: Experiences and Perspectives of Young Adult Patients in Tunisia
Yosra Berrazaga, Haifa Rachdi, Myriam Saadi, et al.
Bulletin Du Cancer
|
July 10, 2004
[Contribution of serum Cyfra 21-1 in nasopharyngeal carcinoma in Tunisia]
Aouatef Jmal, Hamouda Boussen, Monia Abdennebi, et al.
Breast Disease
|
March 6, 2018
Forkhead box M1 (FOXM1) expression predicts disease free survival and may mediate resistance to chemotherapy and hormonotherapy in male breast cancer
Syrine Abdeljaoued, Lhem Bettaieb, Meher Nasri, et al.
La Tunisie Medicale
|
February 8, 2008
[Seric soluble interleukin-2 receptor alpha in nasopharyngeal carcinoma in Tunisia. Prospective study about 45 cases]
Aouatef Jmal, Abderraouf Ghanem, Hamouda Boussen, et al.
Journal of Oral Science
|
June 23, 2017
HLA-A*26-A*30 and HLA-DRB1*10 could be predictors of nasopharyngeal carcinoma risk in high-risk Tunisian families
Nehla Mokni-Baizig, Yosr Gorgi, Mohamed Elghourabi, et al.
Presse Medicale (Paris, France : 1983)
|
December 24, 2014
[Medical therapies for locally advanced/metastatic kidney cancer]
Mehdi Afrit, Yosra Yahyaoui, Aderrazek Bouzouita, et al.
Page
of 11